NKGen Biotech (@NKGenBiotech) header
NKGen Biotech (@NKGenBiotech) profile picture

NKGen Biotech

@NKGenBiotech

NKGen Biotech (OTC:NKGN) is leveraging the power of a patient’s immune system through the development of unique natural killer (NK) cell therapies

 Santa Ana, CA
nkgenbiotech.com/
Joined May 2019
  • Tweets263
  • Following0
  • Followers311
115Media
Photo by NKGen Biotech (@NKGenBiotech)Photo by NKGen Biotech (@NKGenBiotech)Photo by NKGen Biotech (@NKGenBiotech)Photo by NKGen Biotech (@NKGenBiotech)Photo by NKGen Biotech (@NKGenBiotech)Photo by NKGen Biotech (@NKGenBiotech)Photo by NKGen Biotech (@NKGenBiotech)Photo by NKGen Biotech (@NKGenBiotech)Photo by NKGen Biotech (@NKGenBiotech)Photo by NKGen Biotech (@NKGenBiotech)
NKGen Biotech retweeted
mendelspod (@mendelspod) profile picture
mendelspod@mendelspod28 Nov 2023
Supercharged Killer Cells Effective Against Alzheimer’s: Paul Song, CEO @NKGenBiotech mendelspod.com/p/supercharge… #killercells #Immunotherapy #Alzheimer
Supercharged Killer Cells Effective Against Alzheimer’s: Paul Song, CEO, NKGen Biotech

Supercharged Killer Cells Effective Against Alzheimer’s: Paul Song, CEO, NKGen Biotech

Our guest today introduced us to a new kind of immunotherapy called Super-NK. Imagine CAR-T, but in this case, the immune cells from the patient are not engineered, but rather “supercharged.” What’s...

mendelspod.com
4
3
317
NKGen Biotech retweeted
Affimed (@affimed) profile picture
Affimed@affimed27 Apr 2022
📢 Save the date: the 2022 ASCO Annual Meeting is taking place June 3-7, and Affimed announces the acceptance of 4 abstracts, including one oral presentation. Find more information here: bit.ly/3ERGBu4 #ASCO2022 #CancerResearch
Image from Affimed (@affimed)
1
7
2
23
NKGen Biotech retweeted
Affimed (@affimed) profile picture
Affimed@affimed31 Mar 2021
We are excited to announce the FDA has cleared the IND application for a Phase 1/2a study of our innate cell engager in combination with @NKMaxAmerica’s autologous NK cell product. Read the full press release here: bit.ly/2PdIsUX #immunooncology
Image from Affimed (@affimed)
1
11
7
33
NKMax America Announces Acceptance of Three Abstracts at the American Society of Clinical Oncology (ASCO) Annual Meeting globenewswire.com/news-relea…
3
2
4
NKMax America Vice-Chairman & CMO, Dr. Paul Song, is presenting next week at the @CowenGroupInc’s 40th Annual Healthcare Conference on Wednesday, March 4. For more information about their pipeline and natural killer cell technology, visit nkmaxamerica.com/pipeline/ #celltherapy
Image from LifeSci Advisors (@LifeSciAdvisors)
2
3
Load more